Although there has been no research focusing on the potential of combining anti-inflammatory and pro-inflammatory cytokine-targeted therapies to achieve synergistic effects and better disease control, studies showing anti-TNF-α, for instance, result in IL-10 induction in IBD [155]. Here, TNF is linked to inflammatory bowel disease.